- Home
- SKX vs HALO Comparison
SKX vs HALO Comparison
Compare SKX & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKX
- HALO
- Stock Information
- Founded
- SKX 1992
- HALO 1998
- Country
- SKX United States
- HALO United States
- Employees
- SKX N/A
- HALO N/A
- Industry
- SKX Shoe Manufacturing
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SKX Consumer Discretionary
- HALO Health Care
- Exchange
- SKX Nasdaq
- HALO Nasdaq
- Market Cap
- SKX 6.9B
- HALO 7.4B
- IPO Year
- SKX 1999
- HALO N/A
- Fundamental
- Price
- SKX $61.49
- HALO $65.87
- Analyst Decision
- SKX Buy
- HALO Buy
- Analyst Count
- SKX 13
- HALO 9
- Target Price
- SKX $70.33
- HALO $63.78
- AVG Volume (30 Days)
- SKX 10.8M
- HALO 2.0M
- Earning Date
- SKX 04-24-2025
- HALO 05-06-2025
- Dividend Yield
- SKX N/A
- HALO N/A
- EPS Growth
- SKX 9.64
- HALO 55.40
- EPS
- SKX 4.16
- HALO 3.76
- Revenue
- SKX $9,129,335,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- SKX $9.70
- HALO $20.06
- Revenue Next Year
- SKX $8.17
- HALO $24.20
- P/E Ratio
- SKX $14.77
- HALO $17.52
- Revenue Growth
- SKX 10.66
- HALO 25.64
- 52 Week Low
- SKX $44.50
- HALO $41.28
- 52 Week High
- SKX $78.85
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- SKX 68.73
- HALO 58.99
- Support Level
- SKX $46.74
- HALO $58.38
- Resistance Level
- SKX $61.70
- HALO $70.51
- Average True Range (ATR)
- SKX 1.33
- HALO 2.50
- MACD
- SKX 1.95
- HALO 0.88
- Stochastic Oscillator
- SKX 97.05
- HALO 64.61
About SKX Skechers U.S.A. Inc.
Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.